Quotient Therapeutics

Quotient Therapeutics

Discover how Quotient is pioneering a new field of genetics with somatic genomics to unveil a universe of genetic information and develop new therapies.

Total raised
$50M
Latest round
Seed
Employees
76

About Quotient Therapeutics

We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com

Funding & revenue at Quotient Therapeutics

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Total capital raised

$50M

1 known investor

Latest round

Seed · $50M

Nov 2023

Investors

Flagship Pioneering

Growth signals

How fast Quotient Therapeutics is adding people, roles, and audience.

Employees

76

Reported band 51-200

LinkedIn followers

8.2K

+22.5% year over year

Headcount change

MoM
0%

0 people

QoQ
-2.6%

-2 people

6mo
+4.1%

+3 people

YoY
+2.7%

+2 people

2yr
+61.7%

+29 people

Team composition

Where Quotient Therapeutics concentrates its people — a read on which function a fractional leader would plug into.

By function

  • Research4255%
  • Business Development1317%
  • Engineering79%
  • Operations34%

By region

  • United Kingdom47
  • England, United Kingdom43
  • United States28
  • Greater Boston27
  • Massachusetts, United States27
  • Cambridge19

Inside Quotient Therapeutics

What the business focuses on, where it operates, and how employees rate it.

Categories

BiotechnologyLife ScienceMedical

Markets

PRIVATE

Offices

  • Chesterford Research Park, Little Chesterford, England, GB

No open roles right now — view past roles below

Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed August 16, 2026.

About this page

This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Quotient Therapeutics, you can claim this page to manage and enhance it.